PDGI (PDGI)
All Pro Portfolios with PDGI
- Total Pro Portfolios with PDGI:
- Excelsior Small Cap - UMLCX
- show more
- 1
All Do-It-Yourself Portfolios with PDGI
- Total Do-It-Yourself Portfolios with PDGI:
- Dustin Ma Portfolio 1
- Jay Allen Portfolio 1
- Bob Barraza Portfolio 1
- rshsu2007 Portfolio 1
- overrun
- albervel Portfolio 1
- AG Top10
- thomasbaule Portfolio 1
- BENITRANS EO(SUPRATRADE)
- duo
- Aaron67 Portfolio 1
- show more
- 22
- Lee Donais Portfolio 1
- diongameritrade
- Mo Money Portfolio 1
- What Worked in the Barron's Stockpicking Contest
- To the stars
- chanrane Portfolio 1
- bonnieann Portfolio 1
- gator bait
- souma Portfolio 1
- BENITRANS HH
- 2008 Strategy
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:Pro |
Date:11 30 -1 |
PharmaNet Development (PDGI) was downgraded to Hold rating from Buy at Jefferies. Price target slashed to $15 and FY08 eps estimates cut to $0.08 from $1.55. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
PharmaNet Development (PDGI) was downgraded to Hold rating from Buy at Jefferies. Price target dips to $37 from $39 while FY 2008 eps estimates upped to $1.71 from $1.51. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
PharmaNet Development (PDGI) was upgraded to Buy rating from Hold at Jefferies. Price target lifts to $39 from $30 and FY08 eps estimates upped to $1.71 from $1.51. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by Robert W. Baird from Underperform to Neutral |
|
Not yet rated
Rate now:
|
|
Date:01 26 07 |
|
PharmaNet Development Group Inc., formerly SFBC International, Inc., is a global drug development services company, providing a range of both early and late-stage clinical drug development services to branded pharmaceutical, biotechnology and generic drug and medical device companies around the world. |
|
Not yet rated
Rate now:
|
|
Date:01 19 07 |
|
Bought it on a correction...think it has great upside |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |